CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

Also called NCT06463561

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06463561
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06463561. Randomized; no masking; primary purpose treatment. Start 2024-07-12 (actual); primary completion 2027-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea
Acronym
CPAPLIP
Condition
Sleep Apnea
Condition
Dyslipidemias
Condition
Hyperuricemia
Intervention (Device)
Continuous positive airway pressure
Intervention (Other)
Hygienic-dietary recommendations and daily physical activity promotion
Lead sponsor
Hospital Universitario La Paz (class: other)
Collaborator
Hospital Universitario del Henares (class: not stated)

Record details

Record id
cardio:ct-nct06463561
Content hash
974d637a86a5a291dc8669e224f6e82bd7cda75eeef63a9ad2c32394595c1721